During the process of death receptor-mediated apoptosis, Bid is cleaved by activated caspase-8, and then cleaved Bid conveys apoptotic signals to the mitochondria by activating Bax/Bak. In the present study, we found that D609 (an antitumor drug with multiple activities) blocks Fasinduced apoptosis. D609 did not interfere with activation of caspase-8 and cleavage of Bid, whereas it blocked cytochrome c release from the mitochondria by inhibiting the activation of Bax and Bak. D609 had no protective effect against apoptosis of SKW6.4 cells, which are typical type I cells. Studies using permeabilized cells revealed that in addition to activation of caspase-8, Fas activated a distinct and D609-sensitive signaling pathway that transmitted signal(s) sensitizing the mitochondria to apoptotic stimuli, and that D609 itself promoted mitochondrial resistance to apoptotic stimuli.
Introduction
Stimulation of death receptors such as Fas and TNFa triggers an apoptotic cascade, initially by recruiting a death receptor, adaptor protein Fas-associated death domain protein, and procaspase-8, to form the deathinducing signaling complex (DISC), after which procaspase-8 is cleaved and activated (Kischkel et al., 1995; Boldin et al., 1996; Wallach et al., 1999) . Two distinct Fas-induced apoptotic signaling pathways, the choice of which mainly depends on the extent of caspase-8 activated at the DISC, have been described (Scaffidi et al., 1998) . In type I cells, there is extensive activation of caspase-8, which is sufficient to activate downstream execution caspases such as caspase-3 or -7 that commit the cell to death. In type II cells, however, the DISC causes little activation of caspase-8; therefore, mitochondria-mediated amplification of apoptotic signals is necessary (Scaffidi et al., 1998) . In type II cells, activated caspase-8 cleaves and activates a BH3-only protein, Bid (Li et al., 1998a; Luo et al., 1998) , which conveys apoptotic signals to the mitochondria by activating proapoptotic molecules Bax or Bak to induce mitochondrial release of cytochrome c (Desagher et al., 1999; Eskes et al., 2000; Wei et al., 2000) . After it is released into the cytoplasm, cytochrome c binds to apoptotic protease-activating factor 1 (Apaf1), which recruits and activates procaspase-9 to trigger activation of the caspase cascade and commit the cell to apoptotic death (Liu et al., 1996; Li et al., 1997) .
In addition to the caspase-8/Bid signaling pathway, Fas has also been reported to stimulate other signaling pathways, leading to the activation of extracellular signal-regulated kinase (ERK) (Shinohara et al., 2000; Desbarats et al., 2003; Lambert et al., 2003) , c-Jun Nterminal kinase (JNK) (Yang et al., 1997) , tyrosine kinase (Eischen et al., 1994) , acidic sphingomyelinase (aSMase) (Cifone et al., 1995) , or phosphatidylcholinespecific phospholipase C (PC-PLC) (Cifone et al., 1995) . However, little is known about the role of these pathways in the regulation of apoptosis. Our previous study has revealed that Fas stimulates a caspase-8-independent signaling pathway, and although this pathway may not be able to induce directly apoptosis, it sensitizes the mitochondria to apoptotic stimuli by causing exposure of the N-terminus of Bak (Zhang et al., 2004) . These results suggested that in addition to the caspase-8/Bid pathway, Fas stimulates other signaling pathway(s) to regulate apoptosis, although the precise mechanisms are still to be determined.
The xanthogenate tricyclodecan-9-yl (D609) was originally developed as a selective antitumor drug (Amtmann and Sauer, 1987) , and now is also known as an antioxidant (Zhou et al., 2001 ) and inhibitor of PC-PLC and SMase (Schutze et al., 1992; Wiegmann et al., 1994; Amtmann, 1996) . It has been reported that D609 impairs TNF-mediated cytotoxicity in murine fibrosarcoma L929 cells and WEHI164 cells, protects mice against TNF-, LPS-, or SEB-mediated lethal shock (Machleidt et al., 1996) , and inhibits glutamate-induced nerve cell death (Li et al., 1998b) . In the present study, we showed that D609 protected cells from Fas-induced apoptosis, not by interfering caspase-8/Bid activation but by inhibiting the activation of Bak and Bax through blockage of caspase-8/Bid-independent apoptotic signaling and by increasing mitochondrial resistance to apoptotic signals.
Results

D609 inhibits Fas-induced apoptosis in Hela and Jurkat cells
To develop a better understanding about Fas-induced apoptosis, we examined the influence of a variety of inhibitors on apoptosis induced by an agonistic anti-Fas antibody CH11 in Hela cells. We found that D609 inhibited CH11-induced apoptosis in a dose-dependent manner, as assayed by Annexin-V staining (Figure 1a and b), nuclear morphology (Figure 1c) , and activation of caspase-3 (Figure 1d ). D609 also protected Jurkat cells from CH11-induced apoptosis (Figure 1e ). In contrast, D609 did not have any protective effect against CH11-induced apoptosis of SKW6.4 cells, which are typical type I cells (Figure 2a and b) . These results suggested that D609 might prevent Fas-induced apoptosis by blocking a mitochondria-mediated apoptotic signaling pathway.
D609 inhibits activation of Bak/Bax and cytochrome c release Next, we attempted to determine the mechanism by which D609 inhibited apoptosis. First, we examined whether D609 had any effect on an initial step in Fasinduced apoptosis, namely activation of caspase-8 and cleavage of Bid. D609 failed to inhibit the cleavage of procaspase-8 (Figure 3a , upper panel) in Hela cells. Cleavage of Bid was slightly delayed (Figure 3a , middle panel), possibly due to inhibition of a caspase feedback pathway, since D609 blocked mitochondria-mediated amplification of apoptosis signaling (see below). To address this issue further, we investigated CH11-induced cleavage of Bid in the presence or absence of D609 in Bcl-2 overexpressing Hela cells. After stimulation by CH11, cleavage of Bid showed the same kinetics To investigate whether D609 inhibited apoptosis upstream of the mitochondria, we examined a series of mitochondrial events occurring during apoptosis. D609 inhibited the release of cytochrome c from the mitochondria in CH11-stimulated Hela cells (Figure 3b and c). Since Bak/Bax is thought to control the mitochondrial release of cytochrome c (Wei et al., 2001) , we investigated whether D609 had any effect on the activation of Bak or Bax. It has been reported that a conformational change and homo-oligomerization of Bax/Bak are closely associated with the activation of these proteins (Gross et al., 1998; Hsu and Youle, 1998; Griffiths et al., 1999; Antonsson et al., 2000; Wei et al., 2000; Cheng et al., 2003) ; therefore, we examined the occurrence of these events in the presence or absence of D609 after CH11 stimulation. Employing specific antibodies that only recognized activated Bax/Bak that had undergone a conformational change, we found that D609 inhibited the CH11-induced conformational change of Bak and Bax (Figure 3b and d) . D609 also inhibited translocation of Bax to the mitochondria (Figure 3c) , and inhibited the oligomerization of Bak and Bax in CH11-treated cells (Figure 3e and f). These results suggested that D609 inhibited apoptosis at the mitochondrial level or further upstream.
D609 confers mitochondrial resistance to Bid
Inhibition of Bax/Bak activation and cytochrome c release by D609 suggested that it inhibited apoptotic signaling pathways leading to the mitochondria and/or acted at the mitochondrial level. We examined both possibilities. First, to examine the latter possibility, we employed an in vitro assay using Hela cells permeabilized by digitonin. To examine whether D609 inhibits apoptotic signaling at the mitochondria, Hela cells were incubated with D609 for 30 min or 2 h, and then permeabilized, followed by incubating with various concentrations of recombinant human Bid (rBid) or with isotonic buffer as a negative control. Intriguingly, when Hela cells were incubated with D609 for 2 h, rBid only induced little cytochrome c release in these cells (Figure 4 ), whereas incubation with D609 for a shorter period (30 min) could not inhibit rBid-induced cytochrome c release ( Figure 5b ). These results suggested that D609 could increase mitochondrial resistance to apoptotic stimulation.
D609 inhibits caspase-8-independent apoptotic signaling activated by Fas stimulation
To examine the possibility that D609 also inhibited apoptotic signals to the mitochondria, we also employed a permeabilized cell system. The lysate of cells treated with CH11 for 30 min was used. At 30 min, release of cytochrome c was not detected (data not shown). As shown in Figure 5a , the lysate derived from CH11-treated cells induced almost complete cytochrome c release from the mitochondria when was added to permeabilized cells. However, like lysate derived from untreated cells, the lysate derived from CH11/D609-treated cells did not induce cytochrome c release ( Figure 5a ). The addition of D609 to the lysates in vitro did not have any influence on cytochrome c release ( Figure 5a , lower panel), suggesting that D609 did not have direct protective effect to the mitochondria. These results suggested that Fas stimulation not only activates the caspase-8/Bid pathway but also another signaling pathway to the mitochondria with a D609-sensitive step.
To confirm the existence of a Fas-activated caspase-8-independent signaling pathway to the mitochondria and to investigate whether this pathway could be inhibited by D609, cells were incubated with or without CH11 plus z-VAD-fmk in the presence or absence of D609, or D609 alone. After 30 min, the cells were permeabilized, incubated with different concentrations of rBid, and then cytochrome c release was detected by immunostaining. As shown in Figure 5b , particularly when rBid was added at a low concentration (0.01 mg/ml), it induced very little release of cytochrome c in untreated cells, but it released cytochrome c from the mitochondria in CH11/z-VAD-fmk-treated cells, suggesting that CH11/z-VAD-fmk treatment sensitized the mitochon- (Figure 5b ), indicating that incubation with D609 for a short time could not confer the mitochondria resistance to apoptotic signal. Since Fas-activated caspase-8/Bid pathway is completely inhibited by z-VAD-fmk but not by D609, all these results suggested that D609 could inhibit CH11-induced caspase-8-independent apoptotic signaling to the mitochondria. Similar to the results revealed in Figure 5a , addition of D609 in vitro did not inhibit rBid-induced cytochrome c release (Figure 5b ). To further confirm the inhibition by D609 of CH11-induced caspase-8-independent apoptotic signaling to the mitochondria, caspase-8-deficient murine embryonic fibroblasts (caspase-8 À/À mouse embryonic fibroblasts (MEFs)) were employed. The cells were incubated with or without agonistic anti-mouse Fas antibody (Jo2), Jo2 plus D609, or D609 alone for 4 h, and then cytosols were prepared. Permeabilized Hela cells were incubated with isotonic buffer or various cytosols for 10 min, and then stimulated with or without 0.01 mg/ml rBid. As shown in Figure 5c , any cytosol alone did not induce release of cytochrome c. Treatment with rBid induced the release of cytochrome c from the mitochondria in a small fraction of cells, and preincubation of permeabilized cells with the cytosol derived from control caspase-8
MEFs only slightly enhanced rBid-induced release of Figure 4 D609 promotes mitochondria resistance to Bid. Hela cells were incubated with or without 200 mM D609 for 2 h, permeabilized by incubation with 20 mg/ml digitonin for 3 min at room temperature, and incubated with rBid for 10 min at 371C. As a negative control, isotonic buffer was added instead of rBid. After washing three times, the cells were immunostained with anticytochrome c antibody. Note that cytochrome c release from the mitochondria caused loss of immunoreactivity to cytochrome c antibody due to leakage through the permeabilized plasmamembrane À MEFs were incubated with or without 0.5 mg/ml Jo2, Jo2 plus D609 (200 mM), or D609 (200 mM) alone for 4 h, and then the cytosols were prepared. Cytosols were added to permeabilized Hela cells for 10 min at 371C, followed by incubation with or without rBid (0.01 mg/ml) for 5 min. Isotonic buffer was added instead of rBid as a negative control. After washing three times, immunostaining was done with anti-cytochrome c antibody. Scale bar ¼ 20 mm. Cells in which cytochrome c had been released from the mitochondria were counted Two signaling pathways activated by Fas L Zhang et al cytochrome c, whereas preincubation with the cytosol derived from Jo2-treated cells markedly promoted rBidinduced cytochrome c release (Figure 5c ). This result is consistent with our previous finding (Zhang et al., 2004) . However, the cytosol derived from Jo2/D609-treated cells did not enhance rBid-induced cytochrome c release (Figure 5c ). The cytosol derived from D609-treated cells did not affect rBid-induced cytochrome c release (Figure 5c ), and, when was added to the cytosol derived from Jo2-treated cells, it could not inhibit Jo2 lysateinduced enhancement of rBid-induced cytochrome c release (data not shown). These results further indicated that Fas stimulated a caspase-8-independent apoptotic signaling to sensitize the mitochondria to apoptotic stimuli and this pathway could be prevented by D609.
D609 inhibits caspase-8-independent exposure of the Nterminus of Bak activated by Fas stimulation
Our previous study has revealed that Fas stimulation activates a caspase-8-independent signaling pathway that induces exposure of the N-terminus of Bak, and this change primes Bak for full activation and thus sensitizes the mitochondria to apoptotic stimuli (Zhang et al., 2004) . We examined whether D609 could inhibit this caspase-8-independent signaling pathway. As shown in Figure 6a , D609 completely inhibited CH11-induced caspase-8-independent exposure of the N-terminus of Bak. Since D609 might inhibit CH11-induced caspase-8-independent exposure of the N-terminus of Bak at the mitochondria level, we examined whether it inhibited caspase-8-independent signaling upstream of the mitochondria by employing a permeabilized cell system. As reported previously, cytosol derived from cells incubated with CH11 in the presence of z-VAD-fmk induced exposure of the N-terminus of Bak (Figure 6b ) (Zhang et al., 2004) , while cytosol from cells incubated with CH11 in the presence of z-VAD-fmk plus D609 failed to induce this exposure (Figure 6b ). The addition of D609 to the lysate did not inhibit exposure of the N-terminus of Bak (data not shown). These results further confirmed that other signaling pathway(s) originated from the death receptor to participate in the regulation of apoptosis in addition to caspase-8/Bid pathway.
Discussion
In type II cells, mitochondria-mediated apoptotic signaling plays an essential role in Fas-induced apoptosis, since such apoptosis is completely blocked when mitochondrial permeabilization is prevented either by overexpression of Bcl-2/Bcl-x L (Scaffidi et al., 1998) or deficiency of Bax/Bak (Wei et al., 2001) , while apoptosis is severely delayed when Bid, which transmits apoptotic signals to the mitochondria, is eliminated by genetic alteration (Yin et al., 1999) . Fas stimulation does not only activate the caspase-8/Bid pathway but also other signaling pathway(s) such as ERK (Shinohara et al., 2000; Desbarats et al., 2003) , PC-PLC (Cifone et al., 1995) , JNK (Yang et al., 1997) , and aSMase (Cifone et al., 1995) . To date, whether these pathways play any roles in the regulation of apoptosis is still unclear. Here, we showed that D609 prevents Fas-induced apoptosis not by interfering caspase-8/Bid activation but, at least partly, by inhibiting Fas-mediated caspase-8-independent apoptotic signaling to the mitochondria (Figure 7 ). This result suggested that in addition to caspase-8/Bid pathway, Fas stimulation also activates other signaling to regulate apoptosis. It is currently unclear how D609 inhibited this signaling pathway, since D609 has been reported to inhibit PC-PLC and SMase activity (Schutze et al., 1992; Wiegmann et al., 1994; Amtmann, 1996; Machleidt et al., 1996) , and is also known as an antioxidant (Zhou et al., 2001) . Although the target of D609 has not been identified, D609 has enabled us to identify a novel apoptotic signaling pathway that is activated by Fas and is independent of caspase-8/Bid. Our previous study also revealed that Fas stimulates a caspase-8-independent signaling pathway, which is staurosporine-inhibitable, and, although this pathway may not be able to induce directly apoptosis, it sensitizes the mitochondria to apoptotic stimuli by causing exposure of the N-terminus of Bak (Zhang et al., 2004) . We found that D609 completely inhibited the CH11-induced caspase-8-independent signaling pathway leading to the exposure of Bak N-terminus. These findings also suggested that in addition to the caspase-8/ Bid pathway, Fas stimulates other signaling pathway(s) to regulate apoptosis. We also showed that D609 decreased susceptibility of the mitochondria to apoptotic signal (Figure 7) . Consistently, D609 inhibited not only Fas-induced apoptosis but also etoposide-induced apoptosis (unpublished data). D609 may decrease mitochondrial susceptibility by inhibiting the exposure of N-terminus of Bak, although another possibility exists because D609 also inhibited the activation of Bax. It has been reported that dynamic changes of mitochondrial membrane lipids occur during Fas-and radiation-induced apoptosis (Matsko et al., 2001) . In the present study, we found that Fas stimulation increased PC-PLC activity, and D609, but not caspase inhibitor z-VAD-fmk, inhibited this increased activity (data not shown). PC-PLC is a phospholipase; the hydrolysis of lipid and/or the reaction products could affect lipid homeostasis in the mitochondria. Since Bak is localized on the outer mitochondrial membrane, it is conceivable that changes of the membrane lipids could affect the conformation of Bak. To exert proapoptotic activity, Bax undergoes translocation and is inserted into the mitochondrial membrane, where it oligomerizes to contribute to the formation of a protein-conducting pore (Wolter et al., 1997; Antonsson et al., 2000 Antonsson et al., , 2001 Eskes et al., 2000) . Recent studies have revealed that Bax-induced permeabilization of liposomes is dependent on cardiolipin, which is a specific mitochondrial membrane lipid (Epand et al., 2002; Kuwana et al., 2002) . In the absence of liposomes, tBid failed to induce the conformational change and oligomerization of Bax (Yethon et al., 2003) , suggesting that an appropriate lipid environment is required for Bax to undergo translocation and insertion into the mitochondrial membrane. It is possible that mitochondrial membrane lipids are altered by PC-PLC or other molecule to facilitate the conformational change of Bax, as well as its mitochondrial translocation and membrane insertion. It is currently unclear whether the protective effect of D609 is exerted via inhibition of PC-PLC, and also whether PC-PLC really plays an important role in the regulation of Fas-induced apoptosis, since PC-PLC itself has not been identified in eukaryote. This will be unveiled when eukaryotic PC-PLC is cloned or when other target(s) of D609 are found. Alternatively, death stimulation induces generation of reactive oxygen species (ROS), and ROS influences lipid homeostasis in the mitochondria, therefore promoting activation of Bak or Bax. D609 has been reported as a potent antioxidant, and this effect may interpret that D609 inhibited etoposide-induced apoptosis at the mitochondrial level (unpublished data).
It has been reported that aSMase/ceramide plays an important role in Fas-induced apoptosis and that D609 inhibits aSMase activation (Schutze et al., 1992; Boesende Cock et al., 1999; Lin et al., 2000; Paris et al., 2001 ). Therefore, it is possible that the inhibition of Fasinduced apoptosis by D609 is due to inhibition of aSMase/ceramide. However, this is unlikely, because blocking the production of ceramide with an aSMase inhibitor (imipramine) or an inhibitor of ceramide synthase (fumonisin B1) did not have any protective effect against Fas-induced apoptosis (data not shown), suggesting that aSMase may not participate in this form of apoptosis and that protective effect of D609 is not mediated via inhibition of aSMase in these cells. Identification of true targets of D609 would develop a better understanding about apoptosis regulation.
Materials and methods
Antibodies and Reagents
Anti-Bak (Ab1) monoclonal and polyclonal antibodies were purchased from Oncogene Research Products (Boston, MA, USA) and Upstate Biotechnology (Lake Placid, NY, USA), respectively. Anti-Bax (N20) and anti-Bid polyclonal antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and R&D System (Minneapolis, MN, USA), respectively. Anti-cytochrome c (6H2 and 7H8), anti-Bax (6A7) and anti-mouse Fas (Jo2) monoclonal antibodies were Figure 7 Two independent signaling pathways activated by Fas stimulation in type II cells. Fas activates two distinct signaling pathways to the mitochondria to regulate apoptosis: the caspase8/ Bid-dependent and -independent pathways. Although this caspase-8-independent pathway might not induce apoptosis directly, it sensitizes the mitochondria to apoptosis stimulation. D609 prevents Fas-induced apoptosis by inhibiting the caspase-8-independent signaling pathway to the mitochondria as well as protecting the mitochondria Two signaling pathways activated by Fas L Zhang et al from Pharmingen (San Diego, CA, USA). Anti-human Fas (CH11), anti-caspase-3, and anti-caspase-8 monoclonal antibodies were obtained from MBL (Nagoya, Japan), while antilamin B1 and anti-active caspase-3 antibodies were purchased from Zymed Laboratories (San Francisco, CA, USA) and Promega (Madison, WI, USA), respectively. All of the secondary antibodies were purchased from Molecular Probes (Eugene, OR, USA). The crosslinker bismaleimidohexane (BMH) came from Pierce Biotechnology (Rockford, IL, USA). D609 was purchased from Calbiochem (San Diego, CA, USA), while the other chemicals were obtained from Sigma (Saint Louis, MS, USA). rBid was prepared as described previously (Shimizu and Tsujimoto, 2000) .
Cell culture
The human Hela cell line, human Jurkat T-leukemic cell line, and human SKW6.4. B lymphoblastoid cell line were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). MEFs derived from caspase-8-deficient mice were grown in Dulbecco's modified Eagle's medium supplemented with 10% FBS.
Immunofluorescence staining
Cells were fixed in 4% parafomaldehyde for 30 min, and then permeabilized with 0.1% Triton X-100 for 15 min at room temperature. After incubation with 2% FBS in phosphatebuffered saline (PBS) for 1 h, the cells were incubated with anti-Bak (Ab1) (1 : 500) or anti-cytochrome c (1 : 500) for 1 h. After washing three times with PBS, the cells were incubated with the secondary antibody (Alexa 488-conjugated antimouse IgG) for 1 h. Then fluorescence was detected under a confocal microscope (Zeiss, LSM510). In all immunostaining experiments, normal mouse IgG was added instead of the primary antibody (IgG) as a negative control.
Immunoprecipitation
Hela cells were treated, harvested, and lysed with HNC buffer (25 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM dithiothreitol (DTT), 2% CHAPS). The extracts were precleared, incubated with a monoclonal anti-Bax antibody (6A7) (1 mg) or normal mouse IgG (1 mg) for 3 h at 41C, and then incubated with protein A beads for further 3 h. After washing five times with HNC buffer, the beads were suspended in sample buffer and then were subjected to Western blotting with a polyclonal antiBax antibody (N20).
Analysis of cell death
Cell viability was assessed by staining with Annexin-V or Hoechst 33342. Briefly, cells were stained with Cy3-conjugated Annexin-V or 1 mM Hoechst 33342 for 5 min at room temperature, and then analysed using a flow cytometer or examined under a fluorescence microscope (Olympus, BX50). Cells with condensed and fragmented nuclei were classified as apoptotic cells and were counted in four randomly chosen fields.
Crosslinking
Cells were harvested, incubated with 1 mM BMH for 30 min at room temperature, and then incubated with 1 mM DTT for 15 min to quench the cross-linker. Next, the cells were solubilized in sample buffer and analysed by Western blotting. As a control, the same concentration of Me 2 SO (DMSO) was added instead of BMH.
Permeabilization of cells
Hela cells were cultured in 10-well glass slides. After washing twice with isotonic buffer (20 mM HEPES-KOH (pH 7.4), 1.5 mM MgCl 2 , 10 mM KCl, 250 mM sucrose), the cells were incubated with isotonic buffer containing 20 mg/ml digitonin for 3 min at room temperature. After washing three times with isotonic buffer, the cells were incubated with cytosol, or rBid at 371C. After washing another three times with isotonic buffer, the cells were subjected to immunostaining.
Preparation of cytosol
After washing three times with isotonic buffer, cells were suspended in the same volume of isotonic buffer supplemented with protease inhibitors, and then homogenized using a Dounce homogenizer. After centrifugation at 100 000 g for 1 h, the supernatant was obtained and used as the cytosol.
Subcellular fractionation
Cells were fractionated as described previously (Nomura et al., 1999) . Briefly, the cells were harvested, washed three times with isotonic buffer, and then incubated with 30 mg/ml digitonin in isotonic buffer for 5 min at 371C. After centrifugation at 3000 r.p.m. for 3 min, aliquots of the supernatant (cytosolic fraction) and the pellet (containing the mitochondria) were analysed by Western blotting with anti-cytochrome c and antiBax antibodies.
